Anthony A Bavry

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi request reprint Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature
    Anthony A Bavry
    Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Cardiol 93:830-5. 2004
  2. ncbi request reprint Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device
    Anthony A Bavry
    Department of Interventional Cardiology, Cleveland Clinic, 9500 Euclid Avenue, NO 605, Cleveland, OH 44114, USA
    J Invasive Cardiol 20:152-6. 2008
  3. doi request reprint The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Am Heart J 155:640-7. 2008
  4. ncbi request reprint Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent
    Juhana Karha
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 98:616-8. 2006
  5. doi request reprint Bare metal stent thrombosis 13 years after implantation
    Michael L Sarkees
    Cleveland Clinic, Cleveland, OH, USA
    Cardiovasc Revasc Med 10:58-9. 2009
  6. ncbi request reprint Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 119:1056-61. 2006
  7. ncbi request reprint Understanding and minimizing late thrombosis of drug-eluting stents
    Mark G Rabbat
    Department of Internal Medicine, Cleveland Clinic, OH 44195, USA
    Cleve Clin J Med 74:129-36. 2007
  8. ncbi request reprint Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cardiac, Peripheral, and Carotid Intervention, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiovasc Drugs 7:135-41. 2007
  9. ncbi request reprint Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials
    Thomas J Helton
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiovasc Drugs 7:289-97. 2007
  10. ncbi request reprint Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 48:1319-25. 2006

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature
    Anthony A Bavry
    Harvard School of Public Health, Boston, Massachusetts, USA
    Am J Cardiol 93:830-5. 2004
    ..Enhanced risk stratification is needed in women and troponin-negative patients so that invasive therapy may be more effectively recommended in these groups...
  2. ncbi request reprint Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device
    Anthony A Bavry
    Department of Interventional Cardiology, Cleveland Clinic, 9500 Euclid Avenue, NO 605, Cleveland, OH 44114, USA
    J Invasive Cardiol 20:152-6. 2008
    ..The FISH (femoral introducer sheath and hemostasis) device is novel in that the access sheath and closure component are incorporated onto the same system...
  3. doi request reprint The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Am Heart J 155:640-7. 2008
    ..Accordingly, our aim was to conduct a meta-analysis to assess the benefit and safety profile of drug-eluting stents in diabetic patients...
  4. ncbi request reprint Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent
    Juhana Karha
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 98:616-8. 2006
    ..This finding was present in the BMS and SES groups and highlights the need for aggressive risk-factor modification after PCI...
  5. doi request reprint Bare metal stent thrombosis 13 years after implantation
    Michael L Sarkees
    Cleveland Clinic, Cleveland, OH, USA
    Cardiovasc Revasc Med 10:58-9. 2009
    ..Angiography demonstrated thrombotic occlusion and severe underlying restenosis of the stent. To our knowledge, this is the latest bare metal stent thrombosis described in the world medical literature...
  6. ncbi request reprint Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 119:1056-61. 2006
    ..Drug-eluting stents are commonly used for percutaneous coronary intervention. Despite excellent clinical efficacy, the association between drug-eluting stents and the risk for late thrombosis remains imprecisely defined...
  7. ncbi request reprint Understanding and minimizing late thrombosis of drug-eluting stents
    Mark G Rabbat
    Department of Internal Medicine, Cleveland Clinic, OH 44195, USA
    Cleve Clin J Med 74:129-36. 2007
    ..The aim of this article is to review the incidence, predictors, pathology, and prevention of late thrombosis of drug-eluting stents...
  8. ncbi request reprint Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cardiac, Peripheral, and Carotid Intervention, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Cardiovasc Drugs 7:135-41. 2007
    ..This study sought to determine if the initiation of statin (HMG-CoA reductase inhibitor) therapy during acute coronary syndromes reduces long-term mortality and other adverse cardiac outcomes...
  9. ncbi request reprint Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials
    Thomas J Helton
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiovasc Drugs 7:289-97. 2007
    ..To quantify the impact of clopidogrel plus aspirin on the individual outcomes of death, myocardial infarction, or stroke in patients with established cardiovascular disease, or in patients with multiple risk factors for vascular disease...
  10. ncbi request reprint Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 48:1319-25. 2006
    ..This study sought to systematically determine whether early invasive therapy improves survival and reduces adverse cardiovascular events in the management of non-ST-segment elevation acute coronary syndromes...
  11. ncbi request reprint Risk of thrombosis with the use of sirolimus-eluting stents for percutaneous coronary intervention (from registry and clinical trial data)
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Cardiol 95:1469-72. 2005
    ..Compared with bare metal stents, sirolimus-eluting stents did not appear to increase the risk for thrombosis up to 13.5 months after coronary intervention (risk ratio 0.49, 95% confidence interval 0.22 to 1.12, p = 0.09)...
  12. doi request reprint Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, Ohio, USA
    Am J Cardiol 109:1087-91. 2012
    ..007). In conclusion, although overall mortality rates are similar between men and women undergoing PCI for NSTE-ACS, women <60 years old with negative biomarkers have a higher mortality than their men peers...
  13. doi request reprint Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents
    Mehdi H Shishehbor
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA
    Am Heart J 155:1075-80. 2008
    ..The short-term and long-term safety and efficacy of paclitaxel versus sirolimus-overlapping drug-eluting stents (DES) is unknown. We sought to examine the clinical consequences of overlapping sirolimus versus paclitaxel DES...
  14. ncbi request reprint Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention
    Girish R Mood
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 100:919-23. 2007
    ..4% in the statin arm and 0.08% in the placebo arm (OR 3.00, 95% CI 0.60 to 14.77, p=0.18). In conclusion, statin therapy initiated at the time of elective percutaneous coronary intervention significantly reduces myocardial infarction...
  15. ncbi request reprint Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes
    Juhana Karha
    The Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 98:906-10. 2006
    ..92, 95% confidence interval 0.69 to 1.23, p = 0.59). In conclusion, adjunctive use of platelet GP IIb/IIIa inhibitors in saphenous vein graft PCI does not appear to be associated with less myonecrosis or improved survival...
  16. doi request reprint Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA
    Lancet 371:2134-43. 2008
    ..Many people will do well with a bare-metal stent, whereas for individuals with a high likelihood of restenosis and late thrombosis, medical management or surgical revascularisation might be preferred options...
  17. doi request reprint The optimal treatment of carotid atherosclerosis: a 2008 update and literature review
    Thomas J Helton
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Postgrad Med 120:103-12. 2008
    ..Carotid stenting is currently being investigated as an alternative therapeutic intervention for these patients. This article reviews the literature pertaining to carotid intervention and its current status in 2008...
  18. ncbi request reprint Bare metal stents: no longer passé?
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    J Invasive Cardiol 18:403-4. 2006
  19. ncbi request reprint Drug-eluting stents: can we move beyond stent thrombosis?
    Mark G Rabbat
    Department of Internal Medicine, Cleveland Clinic, Cleveland OH, 44195, USA
    Am Heart Hosp J 5:155-8. 2007
  20. ncbi request reprint Presence of carotid and peripheral arterial disease in patients with left main disease
    Aaron L Doonan
    Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA
    Am J Cardiol 100:1087-9. 2007
    ..In conclusion, compared with patients without LM disease, patients with LM disease have a higher burden of advanced atherosclerosis as evidenced by a higher prevalence of significant carotid stenosis and lower ankle-brachial indexes...
  21. doi request reprint Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials
    Dharam J Kumbhani
    Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA
    Am Heart J 161:622-630.e1. 2011
    ..We sought to systematically evaluate whether percutaneous revascularization is associated with additional clinical benefit in patients with renal artery stenosis (RAS) as compared with medical management alone...
  22. ncbi request reprint A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis
    Taral N Patel
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Cardiol 97:1685-90. 2006
    ..61, 95% confidence interval 0.91 to 14.27, p=0.07). In conclusion, rescue PCI in the setting of early fibrinolytic failure improves mortality, but this is tempered by a possible increase in the risk of thromboembolic stroke...
  23. ncbi request reprint What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis
    Anthony A Bavry
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 45:941-6. 2005
    ..This study investigated the risk of stent thrombosis associated with the use of paclitaxel-eluting stents (PES) compared to bare-metal stents (BMS)...
  24. ncbi request reprint Interpreting observational studies -- look before you leap
    Anthony A Bavry
    Cleveland Clinic Foundation, Department of Cardiovascular Medicine, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195, USA
    J Clin Epidemiol 59:763-4. 2006
  25. ncbi request reprint Routine vs selective invasive strategies in acute coronary syndromes
    Anthony A Bavry
    JAMA 294:2844-5; author reply 2845-6. 2005
  26. ncbi request reprint Development of coronary aneurysm after drug-eluting stent implantation
    Anthony A Bavry
    Ann Intern Med 146:230-2. 2007
  27. ncbi request reprint Acute myocardial infarction
    Thomas J Helton
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, USA
    Am J Med 118:718-9. 2005
  28. ncbi request reprint Drug-eluting stents: dual antiplatelet therapy for every survivor?
    Anthony A Bavry
    Circulation 116:696-9. 2007
  29. ncbi request reprint Designing the ideal risk model for acute coronary syndromes--is simple better than complex?
    Anthony A Bavry
    Am Heart J 154:206-7. 2007
  30. ncbi request reprint Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint?
    Anthony A Bavry
    Am Heart J 153:719-21. 2007